Experimental melanoma vaccine shows promising results
An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients. It's personalized for each patient and optimized using artificial intelligence. Dr. Jon LaPook has more details.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
CBS News (www.cbsnews.com), a Tier B publisher, filed this report on .
Signal breakdown
CurrentWire ranked this story 60.9 of 100 in the snapshot this page was rendered from.
- Freshness
- 31.4 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 31.4 of 35. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Artificial Intelligence (13).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.